Institut Pasteur Korea (IPK) is a private, non-profit research institute dedicated to public health. With world-class drug discovery capabilities and a talented team drawn from all over the world, IPK scientists aim to uncover various physiological and pathological processes to devise new strategies for diagnosing, preventing, and treating disease. IPK currently focuses on global infectious diseases that represent today’s health challenges such as COVID-19, viral immunity, tuberculosis, antibiotic resistance, viral hepatitis, cancer, and neglected diseases, and preparing for emerging diseases that may impact future health needs.